For instance, Novo Nordisk was forced to cut its annual profit expectations back in August following weaker-than-expected ...

Novo’s once-weekly drug, CagriSema, combines semaglutide with another medicine called cagrilintide. The company predicts the ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians can combine, mix, or adjust the ingredients of a medication — to meet ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

The stock of Eli Lilly and Company LLY has declined 10.6% in a month ... Lilly’s tirzepatide medicines face strong ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

25 mg starter dose of semaglutide-based obesity med Wegovy is now available in the U.S. Last month, the FDA removed Eli Lilly ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

which both use a different GLP-1 agonist drug called semaglutide. Eli Lilly CEO Dave Ricks told investors during a call following the announcement that there wasn't a "demand problem here," but ...